Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Ryszard Wichary"'
Autor:
Grzegorz Helbig, Grazyna Bober, Marek Seweryn, Ryszard Wichary, Andrzej Tukiendorf, Lech Sedlak, Tomasz Oleksy, Slawomira Kyrcz-Krzemien
Publikováno v:
Mediterranean Journal of Hematology and Infectious Diseases, Vol 7, Iss 1, Pp e2015003-e2015003 (2015)
Introduction. Imatinib mesylate (IM) remains a treatment of choice for chronic myeloid leukemia (CML) showing a remarkable efficacy and providing a perspective for a long disease-free survival. Due to the long-term administration of IM, the questions
Externí odkaz:
https://doaj.org/article/afe7bca9274c424a800de7df2f5cd3d2
Autor:
Monika Joks, Renata Kasza, Janusz Kloczko, Edyta Paczkowska, R. Kroll-Balcerzak, Elżbieta Patkowska, Olga Grzybowska-Izydorczyk, Monika Biernat, Ryszard Wichary, Wioletta Makowska, Joanna Gora-Tybor, Tomasz Sacha, Malgorzata Wach, Małgorzata Kopera, Marta Oller, Aleksandra Kostyra, Hanna Ciepluch, Joanna Niesiobedzka-Krezel, Joanna Wasilewska, Anna Rudkowska-Kazanowska, Magdalena Swiniarska, Grazyna Bober, Paulina Dumnicka, Witold Prejzner, Ewa Wasilewska, Tomasz Gromek, Elżbieta Szczepanek, Justyna Gil
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 22:405-415
Introduction: Tyrosine kinase inhibitors (TKIs) have greatly improved the treatment outcome for most patients with chronic myeloid leukemia (CML). Ponatinib is a new pan-inhibitor of TK active in resistant CML. This study aimed to evaluate the effica
Autor:
Bartosz Pula, Ewa Bodzenta, Dorota Zdunczyk, Małgorzata Rydzanicz, Iwona Sokolowska-Giezgala, Katarzyna Warzybok, Marcin M Machnicki, Magdalena Olszewska-Szopa, Anna Labedz, Jolanta Wieczorek, Dominika Wisniewska-Organek, Tomasz Stoklosa, Kamila Kruczkowska-Tarantowicz, Krzysztof Jamroziak, Marek Dudziński, Zofia Spyra-Gorny, Rafał Płoski, Dariusz Kumorek, Monika Pepek, Alina Urbanowicz, Elzbieta Morawiec-Szymonik, Agnieszka Szeremet, Pawel Bernatowicz, Agnieszka Pollak, Ryszard Wichary, Waldemar Tomczak
Publikováno v:
Acta Haematologica Polonica. 52:94-102
Indtroduction and methods: In chronic lymphocytic leukemia (CLL), molecular and cytogenetic diagnostics are crucial for the determination of accurate prognosis and treatment choice. Among different genetic aberrations, del(17p13) or TP53 mutations co
Autor:
Marek Dudziński, Monika Długosz-Danecka, Małgorzata Wojciechowska, Michal Osowiecki, Elżbieta Iskierka-Jażdżewska, Weronika Piszczek, Jan Maciej Zaucha, Agnieszka Szymczyk, Edyta Subocz, Joanna Drozd-Sokołowska, Anna Waszczuk-Gajda, Beata Kumiega, Krzysztof Giannopoulos, Ryszard Wichary, Marek Hus, Bartosz Pula, Wojciech Jurczak, Tadeusz Robak, Bożena Katarzyna Budziszewska, Janusz Hałka, Wanda Knopinska-Posluszny, Krzysztof Jamroziak, Agnieszka Szeremet, Andrzej Pluta, Daria Zawirska, Paweł Steckiewicz, Jadwiga Hołojda, Ewa Lech-Marańda
Publikováno v:
Anticancer Research. 40:4059-4066
Background/aim To study the long-term clinical efficacy and tolerability of ibrutinib monotherapy in real-world relapsed and refractory chronic lymphocytic leukemia (RR-CLL) patients outside clinical trials. Patients and methods Clinical data of 171
Autor:
Dariusz Wołowiec, Daria Zawirska, Jolanta Graboś-Michalak, D. Krochmalczyk, Bożena Bramowicz-Jarosz, Stanisław Potoczek, Maria Soroka-Wojtaszko, Monika Długosz-Danecka, Marek Seweryn, Ewa Wąsik-Szczepanek, Agnieszka Szymczyk, Iwona Hus, Ryszard Wichary, Małgorzata Raźny, Agata Malenda, Agnieszka Kopacz, Magdalena Piotrowska
Publikováno v:
Chemotherapy. 64:155-162
Bendamustine is a cytostatic drug with a unique structure, combining the features of purine nucleoside analogs and alkylating agents. In patients with chronic lymphocytic leukemia (CLL) it is commonly used in combination with rituximab (BR protocol)
Autor:
Małgorzata Kopera, Ewa Medras, Renata Kasza, Aleksandra Kostyra, Anna Rudkowska-Kazanowska, Monika Joks, Ryszard Wichary, Edyta Paczkowska, Joanna Niesiobedzka-Krezel, Magdalena Swiniarska, R. Kroll-Balcerzak, Elżbieta Patkowska, Olga Grzybowska-Izydorczyk, Hanna Ciepluch, Elżbieta Szczepanek, Tomasz Sacha, Justyna Gil, Janusz Kloczko, Wioletta Makowska, Paulina Dumnicka, Marta Oller, Malgorzata Wach, Witold Prejzner, Grazyna Bober, Joanna Wasilewska, Joanna Gora-Tybor, Ewa Wasilewska, Tomasz Gromek
Publikováno v:
Blood. 136:40-41
Introduction Tyrosine kinase inhibitors (TKIs) have transformed outcomes in chronic myeloid leukemia (CML). Patients who respond to imatinib, have a life expectancy comparable with that of the global population, however, up to 40% of patients discont
Autor:
Anna Kopińska, Ryszard Wichary, Grzegorz Helbig, Slawomira Kyrcz-Krzemien, Jacek Pająk, Anna Kołda
Publikováno v:
Acta Haematologica Polonica. 48:130-134
Introduction: Metastases of solid tumors to the bone marrow are rarely reported. Clinical manifestation and laboratory findings remain uncharacteristic and lead to misdiagnosis. Detection of bone marrow metastases may have an impact on therapeutic de
Autor:
Anna Dmoszynska, Mariusz Janczarski, Grzegorz Charliński, Pawel Bernatowicz, Ewa Lech-Marańda, Agnieszka Szeremet, Anna Waszczuk-Gajda, Alina Swiderska, Renata Guzicka-Kazimierczak, Norbert Grzasko, Andrzej Szczepaniak, Artur Jurczyszyn, Ryszard Wichary
Background Patients with relapsed/refractory multiple myeloma (RRMM) have poor prognosis. Pomalidomide is an immunomodulatory compound that has demonstrated activity in MM patients with disease refractory to lenalidomide and bortezomib. Objectives Pa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c397661dbfc15ef7922cd1d4e9ab49e4
https://ruj.uj.edu.pl/xmlui/handle/item/122642
https://ruj.uj.edu.pl/xmlui/handle/item/122642
Publikováno v:
Medical Oncology (Northwood, London, England)
Letter to Editor Sustained remission after ABVD treatment for interdigitating dendritic cell sarcoma
Autor:
Jacek Pająk, Grzegorz Helbig, Maria Budny, Slawomira Kyrcz-Krzemien, Ryszard Wichary, Klaudyna Machura, Małgorzata Makowska, Marcin Kubeczko
Publikováno v:
Współczesna Onkologia. 1:83-85
Interdigitating dendritic cell sarcoma (IDCS) is an extremely rare neoplastic proliferation of dendritic cells [1]. EBV and HSV8 viral infections are thought to be involved in its pathogenesis, but understanding their role requires further studies [2